WorldPharmaNews
  • Home
  • Business
  • Research
  • Events
  • Regulatory

FDA

The U.S. Food and Drug Administration (FDA), an agency within the U.S. Department of Health and Human Services, promotes and protects the public health by, among other things, assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

www.fda.gov

FDA RSS Channel

Filters
List of articles in category FDA
Title Published Date
FDA approves first drug to show survival benefit in liposarcoma 28 January 2016
FDA approves first drug to treat a rare enzyme disorder in pediatric and adult patients 08 December 2015
FDA approves Opdivo to treat advanced form of kidney cancer 24 November 2015
FDA approves new treatment for HIV 06 November 2015
FDA approves Praxbind, the first reversal agent for the anticoagulant Pradaxa 19 October 2015
FDA approves new injectable drug to treat schizophrenia 09 October 2015
FDA approves Keytruda for advanced non-small cell lung cancer 05 October 2015
FDA approves first treatment for sexual desire disorder 19 August 2015
FDA takes action to protect consumers from potentially dangerous counterfeit medicines and devices sold online 03 July 2015
FDA approves anti-clotting drug Savaysa 15 January 2015
FDA warns consumers about fraudulent Ebola treatment products 14 August 2014
FDA issues guidance to support the responsible development of nanotechnology products 25 June 2014
FDA launches openFDA to provide easy access to valuable FDA public data 13 June 2014
FDA requires removal of certain restrictions on the diabetes drug Avandia 26 November 2013
FDA approves new drug to treat HIV infection 15 August 2013
FDA alerts companies to stop illegal sale of treatments for diabetes 23 July 2013
FDA takes action to protect consumers from dangerous medicines sold by illegal online pharmacies 27 June 2013
FDA obtains waiver from European Commission to facilitate export for U.S. pharmaceutical manufacturers 23 June 2013
FDA budget requests $4.7 billion 11 April 2013
FDA alerts health care providers of recall of anemia drug Omontys 24 February 2013
  • Start
  • Prev
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • Next
  • End

Business & Industry

  • Roche enters partnership with the Global Fund to support low- and middle-income countries in strengthening critical diagnostics infrastructure
  • Nearly 700,000 US hospitalizations and 110,000 deaths prevented from the Pfizer-BioNTech COVID-19 vaccine
  • Pfizer and BioNTech provide update on COVID-19 vaccine supply agreement with European Commission
  • Roche pledges to extend commitment to the World Federation of Hemophilia Humanitarian Aid Program to 2028
  • Pfizer to acquire Biohaven Pharmaceuticals

Research & Development

  • "Natural immunity" from omicron is weak and limited, study finds
  • mRNA booster vaccines may be a good investment in developing countries
  • Blocking spike captors to counter COVID
  • Recurring brain tumor growth is halted with new drug
  • Investigational COVID mucosal vaccine protects against disease and transmission
  • Using AI to analyze large amounts of biological data
  • Cognitive impairment from severe COVID-19 equivalent to 20 years of ageing, study finds

Conferences & Events

  • Pharma join together to achieve new standards in digital and patient innovation for clinical transformation
  • SMi's 22nd Annual Pain Therapeutics Conference
  • SMi Group Introduces the 4th Annual Injectable Drug Delivery Conference 2022
  • SMi's 5th Annual Pharmaceutical Microbiology East Coast Conference
  • SMi's 3rd Annual AI in Drug Discovery Conference
  • SMi's 6th Annual Highly Potent Active Pharmaceutical Ingredients
  • SMi's 9th Annual Conference Pre-Filled Syringes East Coast

Regulatory Affairs

  • FDA urges drug manufacturers to develop risk management plans to promote a dtronger, resilient drug supply chain
  • FDA limits use of Janssen COVID-19 vaccine to certain individuals
  • EMA establishes Cancer Medicines Forum with academia to optimise cancer treatments in clinical practice
  • FDA approves first generic of Symbicort to treat asthma and COPD
  • FDA approves treatment for wider range of patients with heart failure
  1. You are here:  
  2. Home
  3. FDA
  4. FDA launches global operation to crack down on websites selling illegal, potentially dangerous drugs

About

  • Home
  • Advertise
  • Privacy
  • Cookie Preferences
  • Terms of Use
  • Contact

Top News Channels

  • Industry
  • Research
  • Regulatory

Submit Your News!

Follow / Join us

Didn't we got you connected? If not, please note the following magic buttons:
  • Facebook
  • Twitter
  • LinkedIn
  • XING
  • RSS

Digest World Pharma Newsletter

Subscribe to our weekly Digest Newsletter and stay updated on the latest World Pharma News. Subscribe now, it's free!

© World Pharma News 2022. All Rights Reserved.